APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) include Nobelpharma, Partner Therapeutics, Guangzhou Baiyunshan Pharmaceutical, Harbin Pharmaceutical Group, Hainan Unipul Pharmaceutical, North China Pharmaceutical, Amoytop Biotech and Changchun GeneScience Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), also provides the sales of main regions and countries. Of the upcoming market potential for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales, projected growth trends, production technology, application and end-user industry.

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Company

Nobelpharma

Partner Therapeutics

Guangzhou Baiyunshan Pharmaceutical

Harbin Pharmaceutical Group

Hainan Unipul Pharmaceutical

North China Pharmaceutical

Amoytop Biotech

Changchun GeneScience Pharmaceutical

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Type

Injection

Inhalation

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Application

Cancer Treatment Support

Infectious Disease Treatment

Proteinosis Autoimmune Pulmonary Alveolar

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Inhalation Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Treatment Support Major Manufacturers Table 7. Infectious Disease Treatment Major Manufacturers Table 8. Proteinosis Autoimmune Pulmonary Alveolar Major Manufacturers Table 9. Other Major Manufacturers Table 10. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends Table 11. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers Table 12. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges Table 13. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints Table 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2026) Table 18. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2027-2032) Table 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026) & (K Units) Table 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2027-2032) & (K Units) Table 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021-2026) Table 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2027-2032) Table 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021-2026) Table 28. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers, Product Type & Application Table 32. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2026) Table 39. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2027-2032) Table 40. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 42. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 43. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2026) Table 44. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2027-2032) Table 45. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2026) & (US$/Unit) Table 46. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2027-2032) & (US$/Unit) Table 47. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2026) Table 51. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2027-2032) Table 52. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 54. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 55. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2026) Table 56. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2027-2032) Table 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2026) & (US$/Unit) Table 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2027-2032) & (US$/Unit) Table 59. Nobelpharma Company Information Table 60. Nobelpharma Business Overview Table 61. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 63. Nobelpharma Recent Development Table 64. Partner Therapeutics Company Information Table 65. Partner Therapeutics Business Overview Table 66. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 68. Partner Therapeutics Recent Development Table 69. Guangzhou Baiyunshan Pharmaceutical Company Information Table 70. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 71. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 73. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 74. Harbin Pharmaceutical Group Company Information Table 75. Harbin Pharmaceutical Group Business Overview Table 76. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 78. Harbin Pharmaceutical Group Recent Development Table 79. Hainan Unipul Pharmaceutical Company Information Table 80. Hainan Unipul Pharmaceutical Business Overview Table 81. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 83. Hainan Unipul Pharmaceutical Recent Development Table 84. North China Pharmaceutical Company Information Table 85. North China Pharmaceutical Business Overview Table 86. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 88. North China Pharmaceutical Recent Development Table 89. Amoytop Biotech Company Information Table 90. Amoytop Biotech Business Overview Table 91. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 93. Amoytop Biotech Recent Development Table 94. Changchun GeneScience Pharmaceutical Company Information Table 95. Changchun GeneScience Pharmaceutical Business Overview Table 96. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 98. Changchun GeneScience Pharmaceutical Recent Development Table 99. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 102. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 103. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 108. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 109. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 116. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 117. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 120. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 121. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 122. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 125. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 126. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2021-2026) & (US$/Unit) Table 127. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2027-2032) & (US$/Unit) Table 128. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 131. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 132. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2021-2026) & (US$/Unit) Table 133. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 139. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 140. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2021-2026) & (US$/Unit) Table 141. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2027-2032) & (US$/Unit) Table 142. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 143. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 144. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 145. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 146. Russia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 147. Spain Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 149. Switzerland Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 150. Sweden Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 151. Poland Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 152. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 153. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 154. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 155. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 156. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2021-2026) & (US$/Unit) Table 157. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2027-2032) & (US$/Unit) Table 158. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 159. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 160. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 161. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 162. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2021-2026) & (US$/Unit) Table 163. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 167. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 168. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 173. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 174. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 181. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 182. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 185. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 186. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 187. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 188. Taiwan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 190. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 193. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 194. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2021-2026) & (US$/Unit) Table 195. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Type (2027-2032) & (US$/Unit) Table 196. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 199. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 200. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2021-2026) & (US$/Unit) Table 201. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Application (2027-2032) & (US$/Unit) Table 202. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 206. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 207. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 208. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2021-2026) & (US$/Unit) Table 209. SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Country (2027-2032) & (US$/Unit) Table 210. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 211. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 212. Chile Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 213. Colombia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 214. Peru Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 216. Israel Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 217. UAE Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 218. Turkey Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 219. Iran Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 220. Egypt Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List Table 224. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Image Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Inhalation Image Figure 6. Other Image Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Treatment Support Image Figure 10. Infectious Disease Treatment Image Figure 11. Proteinosis Autoimmune Pulmonary Alveolar Image Figure 12. Other Image Figure 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2032) Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2032) & (K Units) Figure 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales YoY (2021-2032) & (K Units) Figure 22. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales YoY (2021-2032) & (K Units) Figure 23. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales YoY (2021-2032) & (K Units) Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032) Figure 32. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032) Figure 35. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032) Figure 38. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032) Figure 41. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Type (2021-2032) Figure 42. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Type (2021-2032) Figure 43. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Application (2021-2032) Figure 44. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Application (2021-2032) Figure 45. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country (2021-2032) Figure 46. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country (2021-2032) Figure 47. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Type (2021-2032) Figure 48. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Type (2021-2032) Figure 49. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Application (2021-2032) Figure 50. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Application (2021-2032) Figure 51. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country (2021-2032) Figure 52. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Country (2021-2032) Figure 53. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Type (2021-2032) Figure 54. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Share by Type (2021-2032) Figure 55. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Application (2021-2032) Figure 56. China Granu

Scope & coverage.

Types
  • Injection
  • Inhalation
  • Other
Applications
  • Cancer Treatment Support
  • Infectious Disease Treatment
  • Proteinosis Autoimmune Pulmonary Alveolar
  • Other
Companies covered
  • Nobelpharma
  • Partner Therapeutics
  • Guangzhou Baiyunshan Pharmaceutical
  • Harbin Pharmaceutical Group
  • Hainan Unipul Pharmaceutical
  • North China Pharmaceutical
  • Amoytop Biotech
  • Changchun GeneScience Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Type
  3. 1.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Inhalation
  6. 1.2.4 Other
  7. 1.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Application
  8. 1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer Treatment Support
  10. 1.3.3 Infectious Disease Treatment
  11. 1.3.4 Proteinosis Autoimmune Pulmonary Alveolar
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Dynamics
  1. 2.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
  2. 2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers
  3. 2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges
  4. 2.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region
  3. 3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021-2026)
  5. 3.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2027-2032)
  6. 3.2.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region
  9. 3.4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026)
  11. 3.4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2027-2032)
  12. 3.4.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Manufacturers
  2. 4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Manufacturers
  6. 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers, Product Type & Application
  13. 4.7 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market CR5 and HHI
  16. 4.8.2 2025 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Tier 1, Tier 2, and Tier 3
5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Type
  1. 5.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type
  2. 5.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type
  6. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type
6 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Application
  1. 6.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application
  2. 6.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application
  6. 6.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application
7 Company Profiles
  1. 7.1 Nobelpharma
  2. 7.1.1 Nobelpharma Company Information
  3. 7.1.2 Nobelpharma Business Overview
  4. 7.1.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  6. 7.1.5 Nobelpharma Recent Developments
  7. 7.2 Partner Therapeutics
  8. 7.2.1 Partner Therapeutics Company Information
  9. 7.2.2 Partner Therapeutics Business Overview
  10. 7.2.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  12. 7.2.5 Partner Therapeutics Recent Developments
  13. 7.3 Guangzhou Baiyunshan Pharmaceutical
  14. 7.3.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  15. 7.3.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  16. 7.3.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  18. 7.3.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  19. 7.4 Harbin Pharmaceutical Group
  20. 7.4.1 Harbin Pharmaceutical Group Company Information
  21. 7.4.2 Harbin Pharmaceutical Group Business Overview
  22. 7.4.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  24. 7.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 7.5 Hainan Unipul Pharmaceutical
  26. 7.5.1 Hainan Unipul Pharmaceutical Company Information
  27. 7.5.2 Hainan Unipul Pharmaceutical Business Overview
  28. 7.5.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  30. 7.5.5 Hainan Unipul Pharmaceutical Recent Developments
  31. 7.6 North China Pharmaceutical
  32. 7.6.1 North China Pharmaceutical Company Information
  33. 7.6.2 North China Pharmaceutical Business Overview
  34. 7.6.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  36. 7.6.5 North China Pharmaceutical Recent Developments
  37. 7.7 Amoytop Biotech
  38. 7.7.1 Amoytop Biotech Company Information
  39. 7.7.2 Amoytop Biotech Business Overview
  40. 7.7.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  42. 7.7.5 Amoytop Biotech Recent Developments
  43. 7.8 Changchun GeneScience Pharmaceutical
  44. 7.8.1 Changchun GeneScience Pharmaceutical Company Information
  45. 7.8.2 Changchun GeneScience Pharmaceutical Business Overview
  46. 7.8.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  48. 7.8.5 Changchun GeneScience Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  2. 8.1.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  3. 8.1.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  4. 8.1.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
  5. 8.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  6. 8.2.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  7. 8.2.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  8. 8.2.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
  9. 8.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  10. 8.3.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  2. 9.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  4. 9.1.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
  5. 9.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  6. 9.2.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  8. 9.2.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
  9. 9.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  10. 9.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  2. 10.1.1 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  3. 10.1.2 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  4. 10.1.3 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
  5. 10.2 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  6. 10.2.1 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  7. 10.2.2 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  8. 10.2.3 China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  2. 11.1.1 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  4. 11.1.3 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
  5. 11.2 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  6. 11.2.1 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  8. 11.2.3 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
  9. 11.3 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  10. 11.3.1 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Type
  2. 12.1.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Type (2021-2032)
  5. 12.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Application
  6. 12.2.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Application (2021-2032)
  9. 12.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size by Country
  10. 12.3.1 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Analysis
  2. 13.1.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process
  6. 13.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
  9. 13.2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst